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Iron sulfur (Fe-S) clusters, preassembled on the ISCU
scaffold, are transferred to target proteins or to inter-
mediate scaffolds by a dedicated chaperone-cocha-
perone system. However, themolecularmechanisms
that underlie substrate discrimination and guide
delivery of nascent clusters to specific subsets of
Fe-S recipients arepoorly understood.Here,we iden-
tified interacting partners of the cochaperone HSC20
and discovered that LYR motifs are molecular signa-
tures of specific recipient Fe-S proteins or accessory
factors that assist Fe-S cluster delivery. In succinate
dehydrogenase B, two LYR motifs engage the
ISCU-HSC20-HSPA9 complex to aid incorporation
of three Fe-S clusters within the final structure of
complex II. Moreover, we show that members of the
LYRmotif familywhich assist assembly of complexes
II or III, SDHAF1 and LYRM7, respectively, are HSC20
binding partners. Our studies unveil a network of in-
teractions between HSC20 and LYRmotif-containing
proteins that are key to the assembly and function of
complexes I, II, and III.
INTRODUCTION
Iron sulfur (Fe-S) clusters are essential cofactors, required for
the function of proteins involved in a broad range of cellular pro-
cesses, including electron transport in respiratory chain com-
plexes, photosynthesis, regulatory sensing, and DNA repair. In
contrast to the chemical simplicity of Fe-S clusters, their synthe-
sis involves a complex sequence of catalyzed protein-protein
interactions and coupled conformational changes between
the components of several dedicated multimeric complexes
(Rouault, 2012). The proteins involved in Fe-S cluster (ISC)
biogenesis are evolutionarily conserved, and many insights into
the assembly process have been provided by studies of model
organisms, including bacteria, fungi, and plants (Couturier
et al., 2013; Dos Santos and Dean, 2010; Roche et al., 2013).
In mammalian cells, Fe-S clusters are assembled by a complex
composed of a cysteine desulfurase, NFS1; its binding partner,
ISD11; the ISCU scaffold; and an iron donor or allosteric effector,
frataxin (Rouault, 2012). Studies in bacteria and yeast have
demonstrated that upon assembly of a nascent [2Fe-2S] cluster,
the scaffold protein (IscU in bacteria and Isu in yeast) binds to theCeJ-protein (HscB or Jac1, respectively) through hydrophobic con-
tacts (Ciesielski et al., 2012; Fu¨ze´ry et al., 2011), and to anHSP70
chaperone (HscA or Ssq1) through a conserved LPPVK motif
(Dutkiewicz et al., 2004; Vickery and Cupp-Vickery, 2007). An
ATP-driven conformational change of the HSP70 enhances
transfer of the ISCU-bound cluster to recipient apoproteins or
to secondary scaffolds that then deliver the cluster to specific
subsets of final acceptors (Vickery and Cupp-Vickery, 2007).
HSC20 is the sole human DnaJ type III cochaperone dedi-
cated to Fe-S cluster biogenesis (Uhrigshardt et al., 2010). Muta-
tions in HSC20 and in its orthologs cause defects in Fe-S protein
activities, mitochondrial iron accumulation, and reduced mito-
chondrial respiration in human cell lines (Uhrigshardt et al.,
2010), and in multiple experimental systems, including yeast
(Kim et al., 2001; Voisine et al., 2001) and fly (Uhrigshardt
et al., 2013). The importance of Fe-S biogenesis for human
health is well established, as mutations that affect proteins
involved in the pathway cause several distinctive human dis-
eases (Rouault, 2012). Interestingly, studies of four newly
described syndromes caused by mutations in NUBPL, NFU1,
or BOLA3, and IBA57 (Ajit Bolar et al., 2013; Rouault, 2012)
suggest that transfer of Fe-S clusters from the ISCU-chap-
erone-cochaperone complex depends on selective downstream
pathways, which underscores our lack of knowledge about how
discrete subsets of Fe-S recipients are targeted.
We conducted a high-throughput yeast two-hybrid (Y2H)
screen to search the human proteome for interacting partners
of HSC20, aiming to identify Fe-S proteins and specific molecu-
lar recognition motifs that guide targeting of Fe-S clusters to
appropriate recipients. J-proteins often determine the specificity
of their cognate chaperones (Ciesielski et al., 2012; Kampinga
and Craig, 2010; Pukszta et al., 2010), and their C-terminal
domains can bind substrates (Perales-Calvo et al., 2010; Szabo
et al., 1996), facilitate refolding of denatured proteins, and
enhance cell viability (Lee et al., 2002; Li and Sha, 2005). Here
we found that direct binding of specific targets to the cochaper-
one HSC20 is mediated by affinity of its C terminus for proteins
that bear the LYR motif, a tripeptide that constitutes a major
molecular signature of distinctive Fe-S recipients.RESULTS
The Fe-S Protein, SDHB, Was Among the Binding
Partners of HSC20 Identified in the Y2H Screen
We used a stringent Y2H approach to identify proteins that
directly bind to HSC20. In the HSC20-BD-GAL4 clone, residues
29–235 of mature HSC20 were fused to the DNA-binding domainll Metabolism 19, 445–457, March 4, 2014 ª2014 Elsevier Inc. 445
Figure 1. HSC20 Interacts with SDHB
In Vitro and In Vivo
(A) Three clones from the Y2H library
encoding SDHB were identified as interactants
of HSC20. Growth on plates lacking histidine
(Leu/Trp/His) indicated reconstitution of the
GAL4 transcription factor by direct interaction of
SDHB with HSC20 (first three lanes, top row).
Asnegativecontrols, theHSC20-BD-GAL4plasmid
was cotransformedwithRABEP1orSV40T-Ag and
the three SDHB-AD-GAL4 clones with RABEX5
or p53. The expected interactions of RABEX5-
RABEP1 and p53-SV40 T-Ag promoted growth
and were used as positive controls.
(B–D) HSC20 interacts with SDHB in vivo. (B)
Extracts from HeLa cells transfected with pCMV-
SDHB-F/M or with empty vector (pCMV-Entry-
F/M, as negative control) were subjected to IP
with anti-SDHB or anti-FLAG, followed by IB to
HSC20. (C) IP of endogenous SDHB, followed
by IBs to HSC20 or SDHA on mitochondrial (MIT)
or cytosolic (CYT) fractions. (D) IPs of endogenous
HSC20 or DNAJA2, followed by IBs to SDHB or
SDHA. The cochaperone DNAJA2 did not interact
with HSC20 in vivo (IB to HSC20), indicating that
its selection in the Y2H study was a false positive.
IP of DNAJA2 was used as a control for the
specificity of the interaction between HSC20
and SDHB. (A–D, n = 6 biological samples.) Inputs
were 30% of total used for IPs. See also Figure S1
and Table S1.
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fusion protein was used as a bait to screen a human cDNA library
(from HeLa cells) from which signal peptides had been excised,
and these cDNA sequences were fused to the activation domain
(AD) of GAL4 (AD-GAL4) to generate ‘‘preys.’’ Specific binary in-
teractions between bait and prey in the nucleus of cotrans-
formed yeast cells reconstituted a functional GAL4 transcription
factor, which then switched on the expression of four indepen-
dent reporter genes, AUR1-C, ADE2, HIS3, and MEL1. We
selected for activation of HIS3 using different concentrations of
3-amino-1,2,4-triazole (3-AT) to competitively inhibit histidine
synthesis and to select for high HIS3 activation. Approximately
1 3 106 clones were screened under stringent conditions
(4 mM 3-AT), and 70 prey plasmids were identified. Some of
these represented individual clones that encoded different seg-
ments of the same protein, which reduced the total number of
candidates to 54 (see Table S1 available online). Notably, clones
9, 50a, and 52 encoded residues 69–280, 104–280, and 115–
280, respectively, of succinate dehydrogenase B (SDHB), the
Fe-S subunit of the succinate dehydrogenase (SDH) complex446 Cell Metabolism 19, 445–457, March 4, 2014 ª2014 Elsevier Inc.(Figure 1A). Growth on plates lacking
histidine (Leu/Trp/His) indicated
that HSC20 interacted with the protein
encoded by the prey construct to activate
HIS3 transcription, thus rescuing the
histidine-auxotrophy of the yeast strain.
As negative controls, the HSC20-BD-
GAL4 plasmid was cotransformed with
RABEP1 or SV40 T-Ag and the threeSDHB-AD-GAL4 clones with RABEX5 or p53. The expected in-
teractions of RABEX5-RABEP1 and p53-SV40 T-Ag were used
as positive controls. Pull-down experiments performed with pu-
rified HSC20-FLAG (HSC20-F) and SDHB-HA further confirmed
that HSC20 directly binds to SDHB (Figure S1A).
We validated multiple putative interacting partners of HSC20
by coimmunoprecipitation (coIP) (Table S1 and Figure S1). We
found that HSC20 coimmunoprecipitated LYRM7 (Figure S1B),
the human Rieske Fe-S protein chaperone of complex III (Sa´n-
chez et al., 2013). CoIP experiments confirmed the interaction
of HSC20 with four more candidates from the screening: the
succinyl-coA ligase (GDP-forming) subunit beta, SUCLG2; the
quinone reductase, NQO2; the putative helicase with zinc finger,
HELZ (Figures S1C and S1D); and the bifunctional glutamate-
proline tRNA ligase (EPRS) (Figure S1E). Interestingly, we found
that HSC20 can dimerize, a property shared by several members
of the HSP40 family (Kampinga and Craig, 2010; Shi et al., 2005;
Terada and Oike, 2010). HSC20 was among the positive
clones identified in initial screens (Table S1) and was further vali-
dated in vivo, as endogenous HSC20 coimmunoprecipitated
Figure 2. HSC20 Binds SDHB and Forms a
Complex with HSPA9 and ISCU
(A) Complex formation between HSC20, SDHB,
ISCU, and HSPA9 by reciprocal coIP experiments.
IP of HSC20 or HSPA14, followed by IBs to ISCU,
SDHB, and HSPA14. HSPA14 did not interact
with HSC20 (IB to HSC20) and represented a
false positive from the Y2H screen (left panel).
IP of SDHB, followed by IBs to ISCU, HSPA9,
and HSC20 revealed that there was a complex
composed of SDHB, ISCU, HSPA9, and HSC20
(right panel) (n = 5 biological samples).
(B and C) BN and 2D-BN-SDS IBs of mitochon-
drial extracts resolved three SDHB-containing
complexes of distinctive composition. Red arrows
indicate components of the CIIb complex.
(D) Response of in-gel SDH and SQR activities of
complex II to silencing of HSC20, and rescue by
HSC20-F/M. NT represents a control extract from
cells transfectedwith non-targeting si-RNAs. (B–D,
n = 4 biological samples.) See also Figure S2.
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S1D and S1E). Future experimentsmay uncover other processes
mediated by HSC20-dependent Fe-S transfer, since proteins
involved in DNA/RNA metabolism, energy metabolism, cell-
cycle control, transcription, and translation regulation were
identified in our screen (Table S1), and, among these, SPC25
and GTF2E2 were also present in the MMS19 interaction profile
which previously identified potential cytosolic Fe-S recipients
(Stehling et al., 2012). Interestingly, we detected a prominent
pool of HSC20 in the cytosol, where the cochaperone was found
to specifically interact with the cytosolic proteins EPRS, NQO2,
and HELZ (Figures S1D and S1E).
Binding of HSC20 to SDHB and Formation of the
Chaperone-Cochaperone Transfer Complex in the
Mitochondrial Matrix Is Required for SDH Assembly and
Function
SDHB is the sole Fe-S subunit of complex II (CII), which is situ-
ated at the nexus of two essential energy-generating processes
of the cell, the citric acid cycle andmitochondrial oxidative phos-
phorylation. In eukaryotes, mutations in each of the four nuclear-
encoded succinate-coQ oxidoreductase (SQR) genes (SDHA,
SDHB, SDHC, and SDHD) or associated accessory factors
(SDHAF1 and SDHAF2) account for a variety of clinical pheno-
types, including optic atrophy, myopathy, encephalopathy
(Birch-Machin et al., 2000; Ghezzi et al., 2009), and tumor forma-
tion (Jain-Ghai et al., 2013; Ricketts et al., 2012). We confirmedCell Metabolism 19, 445–4by reciprocal coIP experiments that
HSC20 interacts with SDHB in vivo (Fig-
ures 1B–1D). Endogenous HSC20 was
efficiently coimmunoprecipitated both
with recombinant SDHB-F/M (Figure 1B)
and with endogenous SDHB (Figure 1C).
Conversely, IP of endogenous HSC20
demonstrated that SDHB was coprecipi-
tated (Figure 1D), confirming that SDHB
and HSC20 are binding partners.HSPA9/GRP75/Mortalin was previously identified as the
HSC20 cognate chaperone by a Y2H assay (Uhrigshardt et al.,
2010) and in coIP experiments when the two proteins were
overexpressed (Shan and Cortopassi, 2012). We verified that
endogenous HSC20 specifically interacted in vivo with HSPA9
(Figure S2A), and with ISCU (Figures S2B and S2C), confirming
that the orthologous interactions reported in bacteria and yeast
(Vickery and Cupp-Vickery, 2007; Voisine et al., 2001), and
recently in an in vitro study employing purified human proteins
(Cai et al., 2013), also occur in mammals with HSPA9, but not
with its human homolog, HSPA14 (Figures 2A and S2A). Interest-
ingly, the region containing residues 439–590 of HSPA9 shares
97% similarity with the domain of bacterial HscA that binds
IscU, and the high degree of sequence homology translates
into a remarkable structural conservation between the two
domains (Figure S2D).
To address whether HSC20 works with HSPA9 and ISCU to
enhance acquisition of Fe-S clusters by SDHB, we analyzed
whether SDHB physically interacted with the ISCU-HSC20-
HSPA9 complex, and we observed that SDHB coprecipitates
ISCU, HSPA9, and HSC20 (Figures 2A and S2E). In contrast,
we did not find direct interactions between SDHB and other pro-
posed scaffolds, including ISCA1, ISCA2 (Sheftel et al., 2012), or
NFU1 (Ferrer-Corte`s et al., 2013) (data not shown).
As SDHB likely acquires its Fe-S clusters before entering for-
mation of a multimeric complex with SDHA, SDHC, and SDHD,
we assessed various stages of assembly of the SDH complex57, March 4, 2014 ª2014 Elsevier Inc. 447
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dimensional native-SDS-PAGE (2D-SDS-PAGE) separations, in
combination with immunoblotting (IB). After resolution of mito-
chondrial extracts by BN-PAGE, three SDHB-containing
complexes were identified (Figure 2B), including CII, which con-
formed to the predicted size of fully assembled complex II on
BN-PAGE (220 KDa) (Hao et al., 2009), CIIa, which appeared to
represent an assembly intermediate composed of SDHA and
SDHB (Figure 2B), but not SDHC (Figure 2C), and a third pool
of SDHB (CIIb) (Figure 2B) of approximately 110 KDa (Figure 2C)
which contained SDHB, ISCU, HSPA9 (Figure 2B), and HSC20
(Figure 2C), but not SDHA. CII demonstrated substantial in-gel
SDH and SQR enzymatic activities (Figure 2D). SDH and SQR
activities diminished in cells silenced for HSC20 (si-HSC20) for
48 hr, but the phenotype was specifically rescued by retransfec-
tion with pCMV-HSC20-F/M, demonstrating that HSC20 is
critical for acquisition of CII enzymatic activity (Figures 2D
and S2F). The two bands with SDH activity correspond to the
two distinct bands detected in the native immunoblots to
SDHB and to SDHA (Figure 2B). As the SDHA/SDHB complex
can oxidize succinate into fumarate, CIIa retains SDH activity,
though it lacks the SQR function mediated by subunits A–D of
fully assembled CII.
Using mitochondrial subfractionations, we further showed
that CIIa and CIIb were assembled in the mitochondrial matrix
(Figures 3A–3C). By immunoprecipitating SDHB-HA from the
mitochondrial matrix of HEK293 cells transfected with pCMV-
SDHB-HA, we detected SDHB, HSPA9, and ISCU by native IB,
further confirming the distinctive composition of the CIIb com-
plex (Figure 3D), which localized to the matrix, unlike CII, which
was associated only with mitochondrial membrane lysates
(Figures 3A and 3E).
Complex II Assembly and Enzymatic Activity Are
Impaired in Cells Silenced for HSC20 or HSPA9
To directly examine the effects of knockdowns of HSC20 or
HSPA9 on CII, we measured the SQR activity using an in-gel
assay (Figure 4A). The enzymatic activity of CII in cells silenced
for HSC20 or HSPA9 for 3 days decreased significantly, whereas
SDHB protein levels in total mitochondrial extracts did not
change (Figure 4A, lower panel). However, the fraction of
SDHB that was incorporated into CII decreased upon silencing
of HSC20 or HSPA9, as shown by the native IB to SDHB onmito-
chondrial membrane extracts (Figure 4B), indicating defective
maturation of SDH. Complex I activity and subunit composition
were not affected over the same time period (Figures 4C
and 4D). Prolonged knockdowns of HSC20 or HSPA9 for 7 or
9 days showed early effects on SQR activity (Figure 4E) and
late effects on complex I activity (Figure 4F). SDHB, NDUFS3
(a Fe-S subunit of complex I), and UQCRFS1 (the complex III
Fe-S subunit also known as the Rieske Fe-S protein) protein
levels were significantly reduced after 7 or 9 days of silencing
(Figure S3A), consistent with the known instability of some
Fe-S proteins when they fail to incorporate their clusters. In
contrast, levels of MTCO1, a complex IV subunit that lacks a
Fe-S cluster, and SDHA did not change.
Compromised Fe-S biogenesis due to knockdown of HSC20
or HSPA9 for 7 or 9 days caused apparent cytosolic iron defi-
ciency, as evidenced by changes in IRP1 and IRP2 activities (Fig-448 Cell Metabolism 19, 445–457, March 4, 2014 ª2014 Elsevier Inc.ures S3B and S3C) and concomitant increased TFR1 expression
(Figure S3D), as has been observed previously when Fe-S
biogenesis is impaired (Rouault, 2012).
To examine the effects of knockdown of HSC20 or HSPA9
on SDHB maturation using a complemenatry technique, we
analyzed in vivo iron incorporation into CII using the radioisotope
Fe55 (Stehling et al., 2009). Upon knockdown of HSC20 or
HSPA9 for 5 days, the Fe55 signal of complex II was barely
detectable (Figure 4G), whereas the levels of Fe55 incorpo-
rated into supercomplex S1, which contains complex I (Stehling
et al., 2009), were not diminished.
Further evidence for the importance of HSC20 in the biogen-
esis of SDHB was obtained using a dominant-negative mutant
of HSC20 in which the HPD tripeptide in the J-domain was re-
placed by alanines (HSC20HPD-AAA-F/M), to simulate mutations
that disrupt function of the yeast ortholog of HSC20, Jac1, by
preventing activation of the chaperone (Voisine et al., 2001). By
following the import of in vitro synthesized SDHB-HA into mito-
chondria isolated from cells transfected with pCMV-HSC20-F/
M (Figure S3F) or with the mutant (Figure S3G), we found that
the ability of HSC20HPD-AAA-F/M to interact with SDHB was not
initially impaired (Figure S3G, IB to HSC20), but SDHB did not
progress to form a complex with SDHA over the 30 min time
course (Figure S3G, IB to SDHA). Using Fe55 labeling of imported
SDHB-HA, we demonstrated that the compromised maturation
of SDHB in cells that expressed HSC20HPD-AAA-F/M was due
to failure of the HSPA9/ HSC20HPD-AAA-F/M system to assist
release and transfer of the nascent cluster from ISCU to
SDHB. CIIb did not stably assemble when processing of SDHB
was mediated by HSC20HPD-AAA-F/M (Figure S3H), and the
weak, transient interaction detected in the SDS-PAGE after
IP of SDHB-HA (Figure S3G) did not lead to formation of a pro-
ductive complex, whereas SDHB-HA progressed from CIIb to
CIIa in mitochondria that expressed wild-type HSC20-F/M
(Figure S3H).
The C-Terminal Domain of HSC20 Interacts with SDHB
Using the known crystal structure of human HSC20 (Bitto et al.,
2008) for modeling (Figure 5A), we identified the domain of
HSC20 that mediates the interaction with SDHB by testing N-
and C-terminal constructs of the cochaperone in coIP experi-
ments. We found that the C terminus of HSC20 interacted with
SDHB, whereas the N-terminal domain that contained the HPD
motif bound HSPA9 (Figure 5B) but did not bind SDHB. The C
terminus of HSC20 interacted also with ISCU, and, by testing
mutations of HSC20 analogous to those identified as important
in IscU/Isu binding in bacteria or yeast, respectively (Ciesielski
et al., 2012; Fu¨ze´ry et al., 2011), we determined that residues
L162 and M166 of HSC20 made the greatest contribution to
the binding to ISCU (Figure 5C), whereas Y220 and F221 were
less important. Further inspection of the structure (Bitto et al.,
2008) revealed that the C terminus of HSC20 was composed
of three a-helices (Figure 5A), and helices 1 and 2 were mainly
responsible for mediating the interaction with SDHB in Y2H
assays (Figure S4; Table S2).
SDHB Contains Two L(I)YR Motifs that Bind HSC20
To identify the potential motifs in the SDHB sequence that could
bind HSC20, we subdivided SDHB into multiple peptides and
Figure 3. The CIIb Assembly Intermediate of SDH Localizes to the Mitochondrial Matrix
(A) BN and 2D-SDS IBs to SDHB revealedmultiple SDHB-containing complexes in total mitochondrial lysates which localized to either themembrane fraction (CII,
middle panel) or the matrix (CIIa and CIIb, right panel).
(B) BN-IBs to SDHB, HSPA9, and ISCU on total mitochondrial (Tot Mit) versus mitochondrial matrix fractions (Mit Matrix) verified that CIIa and CIIb localize to the
matrix.
(C) 2D-SDS IBs of mitochondrial matrix fractions showed that CIIb contains the chaperone-cochaperone transfer complex.
(D) BN-IBs to SDHB, HSPA9, and ISCU, after IP of SDHB-HA onmitochondrial matrix fraction from cells transfected with pCMV-SDHB-HA, and elution with 10 or
20 mg/ml HA-peptide, demonstrating that SDHB is found in complexes CIIa and CIIb, which are assembly intermediates of CII.
(E) BN-IB to SDHB on total or mitochondrial matrix extracts from cells transfected with pCMV-SDHB-HA, or the negative control, pCMV-Entry, showing that CIIa
and CIIb are in the matrix, whereas CII is associated to the mitochondrial membrane extracts. (A–E, n = 3 biological samples.)
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Initial deletional analysis of SDHB indicated that two distinct
domains (residues 1–147 and 147–280 of SDHB) were able to
interact with HSC20 in vivo (Figures S5A and S5B) and in vitro
(Figure S5C). Further deletions of SDHB revealed that residues
35–52 (Figure 6A, clone 16) and 237–258 (Figures 6B, clone 18)
interacted with HSC20 and that each contained a highly
conserved L(I)YR motif. To investigate the specific requirement
of the L(I)YR motif for binding to HSC20, the motif residues
were replaced by alanines. Substitutions of the proximal IYR
and the distal LYR motifs into alanines abrogated the interac-Cetions in vitro (Figures 6A and 6B, clones 22 and 23), as did muta-
genesis of the first residue, I or L of each motif into A, (Figures 6A
and 6B, clones 27 and 26). A conserved phenylalanine in SDHB
35–52 (F42) and in SDHB 237–258 (F238) was not important for
binding to HSC20 (Figure 6B, clone 31; Table S3, clone 30).
Further experiments were performed in order to systematically
analyze the requirement of the L(I)YR consensus at different
positions within the primary sequence of SDHB (Figure 6C).
Context was important, as insertion of an LYR motif within the
region 194–240 of SDHB did not confer ability to interact with
HSC20 (Table S3, clone 25). Moreover, en bloc replacement ofll Metabolism 19, 445–457, March 4, 2014 ª2014 Elsevier Inc. 449
Figure 4. Knockdown of HSC20 or HSPA9 Inhibits Complex II Assembly and Activity
(A and B) (A) In-gel activity assay of CII (upper panel), IB to SDHB (lower panel), and BN-IB (B) after knockdown of HSC20 (si-HSC20), HSPA9 (si-HSPA9), HSPA14
(si-HSPA14), or transfection with non-targeting si-RNAs (NT) for 3 days showed decreased CII activity and assembly after HSC20 or HSPA9 silencing, but not
after knockdown of HSPA14, a negative control.
(C and D) (C) Complex I in-gel activity assay, IB to NDUFS3, and BN-IB to NDUFS3 (D), showed that complex I was unaffected by silencing of HSC20 or HSPA9 for
3 days.
(E and F) Spectrophotometric measurements of CII and CI activities showed effects of HSC20 or HSPA9 silencing after 3 days for CII and after 7 days for CI. Error
bars indicate SD from average (A–F, n = 5 biological replicates). (E and F) * t test p value < 0.001.
(G) Fe55 autoradiogram on mitochondrial membrane extracts from silenced cells revealed diminished Fe55 incorporation into CII after silencing of HSC20
or HSPA9. Ft represents cytosolic ferritin, which partially contaminated the mitochondrial preparations, as previously described (Stehling et al., 2009) (n = 3
biological samples). See also Figure S3.
Cell Metabolism
Motifs that Guide Iron Sulfur Cluster Targetingthe tripeptide S198Y199W200 within SDHB 185–240 (Table S3,
clone 7) by LYR did not generate interaction with HSC20
(Table S3, clone 28), suggesting that additional elements such
as secondary structure could affect the interaction. Notably,
the two native L(I)YR consensus sequences in SDHB are located
in unstructured loops of the crystal structure. One of the L(I)YR
motifs appears in SDHB near the N terminus, proximal to the first
cysteines that ligate the [2Fe-2S] cluster, whereas the second is
closer to the C terminus and the cysteinyl ligands of the [4Fe-4S]
and [3Fe-4S] clusters, in positions where binding of the chap-
erone-cochaperone transfer apparatus can guide release of
the cluster from holo-ISCU into the distal Fe-S binding sites of
SDHB.
In several reported cases of familial phaeochromocytomas
and paragangliomas characterized by selective loss of SDH ac-
tivity, the third residue in the IYR motif of SDHB, Arg46, was re-
placed by Gln or Gly (Benn et al., 2003; Ricketts et al., 2012;
Takekoshi et al., 2008). Because of its pathogenic significance
and the fact that it is part of the L(I)YR motif identified here, we
generated an SDHBR46Q for further studies. Although mutation
of the IYR tripeptide within SDHB 35–52 into IYQ did not impair450 Cell Metabolism 19, 445–457, March 4, 2014 ª2014 Elsevier Inc.the intrinsic competence of this short region of SDHB to bind
HSC20 in vitro (Figure 6A, clone 29) in Y2H studies, we found
that SDHBR46Q bound poorly to the HSC20 complex or to
SDHA in vivo (Figures 6D and S5D), impairing the ability to ulti-
mately form a mature SDH complex. To assess how the mutant
was processed, we evaluated Fe55 incorporation into SDHB-F/M
or SDHBR46Q-F/M proteins imported into isolated mitochondria.
The autoradiogram of the imported proteins revealed that iron
incorporation into SDHBR46Q was profoundly diminished in
CIIb (Figure 6E). Furthermore, SDHBR46Q did not progress into
the CIIa complex at the 15 and 30 min time points (Figure 6E,
right side of the gel), unlike wild-type SDHB-F/M (Figure 6E,
left side). These studies suggested that nascent SDHBR46Q did
not incorporate the first Fe-S cluster, which likely rendered the
protein unstable (Figure S5E).
We next determined how SDHBIYR-AAA and SDHBLYR-AAA mu-
tations affected SDH assembly in vivo. As the L(I)YR motifs are
responsible for recruiting the chaperone-cochaperone transfer
apparatus, these mutations of the entire motif were expected
to impair Fe-S cluster acquisition by SDHB, and to thereby pre-
vent the subsequent association with SDHA. Accordingly, we
Figure 5. The C-Terminal Domain of HSC20, Residues 160–235, Provides the Binding Surface for SDHB
(A) 3D structure of HSC20 (PDB ID 3BVO). The N-terminal domain (residues 1–159) is in gold; the C terminus (residues 160–235) is shown in three colors, each
corresponding to one of three helices (1–3), as indicated. The residues substituted by alanines in the region involved in the interaction with ISCU are highlighted in
blue and pointed at by arrows.
(B) Extracts from cells expressing FLAG/MYC-HSC20-N-terminal domain (pCMV-HSC20-N-ter-F/M) or FLAG/MYC-HSC20-C-terminal domain (pCMV-HSC20-
C-ter-F/M) were subjected to IP with anti-FLAG, followed by IBs of the eluates with antibodies to SDHB, ISCU, or HSPA9; results showed that the C terminus
bound to SDHB and ISCU, whereas the N terminus bound HSPA9.
(C) Extracts fromcells expressingHSC20-F/Mor themutants, as indicated,were subjected to IPwith anti-FLAG, followedby IBs to ISCU,SDHB, orHSPA9; results
indicated that residues L162 and M166 were critical for ISCU binding (upper panels). Schematic of the chaperone-cochaperone transfer complex containing
HSC20 wild-type compared to the mutant defective in binding ISCU (lower panel). (B and C, n = 5 biological replicates.) See also Figure S4 and Table S2.
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Motifs that Guide Iron Sulfur Cluster Targetingexpressed SDHBIYR-AAA-F/M and SDHBLYR-AAA-F/M in HEK293
cells, immunoprecipitated recombinant proteins with anti-
FLAG, and evaluated interactions with the chaperone-cochaper-Ceone transfer complex, and with SDHA. Our results showed that
substitution of I44Y45R46 into alanines (SDHB
IYR-AAA-F/M)
completely abrogated the interaction of SDHB with HSC20 andll Metabolism 19, 445–457, March 4, 2014 ª2014 Elsevier Inc. 451
Figure 6. An L(I)YR Motif that Recurs Twice in SDHB Is Recognized by HSC20
(A and B) Deletional analysis of SDHB in Y2H interactions led to identification of the L(I)YR motif in clones 16 (residues 35–52) and 18 (237–258) of SDHB, and
effects of mutagenesis of the motif residues indicated that the SDHB-HSC20 interaction was attributable to the L(I)YR motif.
(C) Sequence of human SDHB, in which L(I)YR motifs are underlined in the peptides analyzed by Y2H in (A) and (B).
(D) IP of SDHB-F/M, SDHBR46Q-F/M, SDHBIYR-AAA-F/M, and SDHBLYR-AAA-F/M with anti-FLAG, followed by IBs to SDHA, HSC20, and HSPA9 demonstrated the
negative effect of mutagenizing L(I)YR motifs. (A, B, and D, n = 5 biological samples.)
(E) Fe55 labeling of SDHB-F/M or SDHBR46Q-F/M imported into mitochondria isolated from HEK293. The IP performed with anti-FLAG on the matrix fraction
showed that the R46Q mutation impaired iron incorporation and complex II biogenesis.
(F) SDHAF1 interacts with HSC20, and with endogenous SDHB (G). (E–G, n = 3 biological samples.) Inputs were 30% of total used for IPs. See also Figure S5,
Table S3, and Table S5.
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Motifs that Guide Iron Sulfur Cluster TargetingHSPA9 (Figure 6D) and, by compromising Fe-S cluster insertion,
was responsible for preventing maturation of SDHB and its sub-
sequent association with SDHA. As SDHBIYR-AAA-F/M retained
a wild-type L240Y241R242 motif at the C terminus, but no interac-
tion with the chaperone-cochaperone transfer apparatus was452 Cell Metabolism 19, 445–457, March 4, 2014 ª2014 Elsevier Inc.detected, we hypothesized that engagement of the first L(I)YR
motif and acquisition of the first Fe-S cluster are prerequisites
for binding of the HSC20-HSPA9-ISCU complex to the second
consensus site. Failure to achieve folding of the N-terminal
domain of SDHB around its [2Fe-2S] cluster prevented further
Cell Metabolism
Motifs that Guide Iron Sulfur Cluster Targetingmaturation of the protein and assembly of the multimeric SDH
complex. Mutations of the second LYR motif in SDHBLYR-AAA-
F/M showed a less profound defect, since there was a readily
detectable interaction with HSC20 and HSPA9 (Figure 6D), sug-
gesting that the first IYR consensus sequence is indispensable
for further maturation of SDHB, whereas loss of the second
LYR site allowed some SDHB to associate with SDHA. Impor-
tantly, mutations of multiple residues in the two L(I)YR motifs of
SDHB, including I44, R46, L240, or R242, cause cancer (Amar
et al., 2005; Celestino et al., 2012; Neumann et al., 2004; Ricketts
et al., 2012).
The LYR motif was present in several proteins selected in the
Y2H (i.e., EPRS and HELZ), and also in LYRM7, an annotated
member of the LYR family (Conserved Domains accession num-
ber cl05087), which contains at least nine proteins in humans,
including SDHAF1, a bona fide CII assembly factor (Ghezzi
et al., 2009), and LYRM4, a component of the initial Fe-S assem-
bly complex (Shi et al., 2009).
The presence of the LYR motif in SDHAF1 appeared to be
particularlymeaningful asSDHactivity is adversely affectedby in-
herited mutations in SDHAF1 in human patients (Jain-Ghai et al.,
2013). ThemissensemutationR55P in theLYRmotif ofSDHAF1 is
associated with SDH-defective infantile leukoencephalopathy
(Ghezzi et al., 2009).We found thatHSC20 interactswithSDHAF1
(Figure 6F). Furthermore, SDHB coimmunoprecipitated SDHAF1
(Figure 6G), and residues 147–280 of SDHB contained an inter-
action site for SDHAF1 (Figure S5F). En bloc substitution of
L240Y241R242 with alanines in SDHB-F/M (SDHB
LYR-AAA-F/M) did
not affect the interaction with SDHAF1 (Figure S5G), indicating
that SDHAF1 interacts with the C-terminal domain of SDHB
(residues 147–280) through a non-LYR binding site.
Identification of a KKX(6-10)KK Consensus
Using Y2H assays, we also discovered that a third binding
region for HSC20 in SDHB, the sequence K267K268X7K276K277,
mediated an interaction with HSC20 (Figure 7A). Interestingly,
GLRX5 has a similar pattern of lysines at its C terminus
(K139K140X10K151K151), and we found that HSC20 interacted
with GLRX5 in vivo (Figures 7B, 7C, and S6). SUCLG2, which
was identified in our screen and confirmed by coIP (Figure S1C),
also contains a K423K424X6K431K432 pattern at the C terminus.
DISCUSSION
Here we have identified a molecular signature, the tripeptide
LYR, which defines Fe-S target proteins through their ability to
bind the cochaperone HSC20 and acquire their Fe-S clusters
from the scaffold protein, ISCU. Upon analyzing SDHB, which
binds to HSC20 directly in Y2H assays, and in vivo in coimmuno-
precipitations, we identified three distinct HSC20 binding sites
that span from the N terminus to the C terminus, including two
iterations of the motif L(I)YR. Despite its relatively simple subunit
composition, the assembly process of SDH has remained
relatively enigmatic (Kim and Winge, 2013; Rutter et al., 2010),
and two accessory proteins have been identified, SDHAF1 and
SDHAF2 (Ghezzi et al., 2009; Hao et al., 2009). In this work, we
uncovered molecular details of how SDHB acquires its three
Fe-S centers, and how assembly of complex II is contingent
upon successful biogenesis of SDHB. Our coIP and proteomicCeapproaches demonstrated that HSC20 physically interacts
with SDHB and works together with its cognate chaperone,
HSPA9, to enhance transfer of Fe-S clusters from the main scaf-
fold ISCU directly to SDHB. Further evidence for this scenario
was provided by mitochondrial subfractionation studies in com-
bination with BN-PAGE and 2D-native/SDS-PAGE analyzes,
which enabled us to characterize an assembly intermediate of
SDH, CIIb. By following the import into isolated mitochondria
of in vitro synthesized SDHB, we found that interaction of
SDHB with the chaperone-cochaperone complex precedes
association with SDHA (Figures 6E, S3F–S3H, and S3L). This
result elucidates a key point in the assembly of complex II. Flavi-
nylation of Sdh1 (the yeast ortholog of the SDHA subunit) was
previously recognized as a prerequisite for complex II maturation
(Kim and Winge, 2013), and our results have now demonstrated
that SDHB must acquire its three Fe-S clusters to enter the pre-
viously unrecognized CIIa intermediate complex composed of
functional SDHA-SDHB subunits. Defective assembly of com-
plex II occurs early in cells silenced for HSC20 or HSPA9, as
shown by reduced levels of SDHB incorporated into CII, by
reduced SDH and SQR activities upon knockdown for 3 days,
and by decreased incorporation of Fe55 into complex II.
By pursuing interactions of HSC20 with SDHB, we identified
two L(I)YR motifs in the SDHB primary sequence, which were
responsible for engaging the chaperone-cochaperone transfer
apparatus and facilitating acquisition of Fe-S clusters during
primary folding of SDHB. Consistent with our mutagenesis anal-
ysis, the motif consists of an aliphatic residue at position 1 (I, L,
or V), followed by a tyrosine or possibly phenylalanine at position
2, and a basic residue (R or K) at position 3. The two LYR motifs
in SDHB are highly conserved throughout the eukaryotic
and prokaryotic kingdoms (Table S5), suggesting that these
consensus sequences have significant functional importance.
Biogenesis of SDHB may require binding of the orthologous
cochaperones to the L(I)YRmotifs in organisms ranging from eu-
karyotes, including plants, to prokaryotes. The ability of HSC20
to bind LYR motifs is underscored by interactions of HSC20
with annotated members of the LYR family, namely SDHAF1
(LYRM8), which is involved in SDH assembly, and LYRM7, which
is required for the biogenesis of the Rieske Fe-S protein of
complex III (Sa´nchez et al., 2013).
Our results show that SDHAF1 also associates with SDHB
through a non-LYR binding site. Based on the physical associa-
tion between SDHAF1 and SDHB, we propose that SDHAF1may
promote Fe-S cluster insertion into SDHB through its ability to
bind HSC20. In our working model (Figure 7E), SDHAF1 associ-
ates with SDHB through a non-LYR binding site and utilizes its
own LYR motif to position an ISCU-HSC20-HSPA9 complex
near to chaperone complexes directly associated with the LYR
binding site(s) of SDHB. The previously observed propensity of
HSC20 to dimerizemay allow two holo-ISCUmolecules at neigh-
boring binding sites to reorganize their adjacent [2Fe-2S] cen-
ters, enabling them to coalesce into the [4Fe-4S] and [3Fe-4S]
clusters of mature SDHB (Chandramouli et al., 2007).
Our in vivo and in vitro approaches to inspect the HSC20-
mediated insertion of Fe-S clusters into SDHB have shed light
on general mechanisms underlying client discrimination, an
event of critical importance in the steps that facilitate Fe-S
cluster transfer from the main scaffold ISCU to specific Fe-Sll Metabolism 19, 445–457, March 4, 2014 ª2014 Elsevier Inc. 453
Figure 7. Residues 255–280 in the C Domain of SDHB Contain a Third Binding Site for HSC20
(A) Y2H on clone 14 of SDHB (255–280), and on peptides in which KK residues of the KKx7KK motif were mutagenized. Mutagenesis of either the first or second
KK dipeptide impaired binding to HSC20 (clones 19 and 21).
(B and C) Endogenous or overexpressed HSC20 interacts with GLRX5 in vivo (A–C, n = 5 biological samples).
(D) 3D structure of porcine SDHB (96% identical to human SDHB; PBD ID 3SFD) showing spatial distribution of HSC20 binding motifs.
(E) Working model for the possible mechanism of Fe-S cluster insertion into the C-terminal domain of SDHB. See also Figure S6 and Table S3.
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Motifs that Guide Iron Sulfur Cluster Targetingrecipient proteins or potential intermediate scaffolds. We pro-
pose that LYR motifs impart specificity by enabling unfolded
target proteins to bind the HSC20-dependent Fe-S transfer
apparatus and directly acquire their clusters.
Notably, complex I, which contains eight Fe-S clusters that
are deeply buried within the 45-subunit multimeric complex, con-
tains twoannotatedmembersof theLYR family, LYRM6 (NDUFA6)
and LYRM3 (NDUFB9), and a Fe-S subunit, NDUFS8, that con-
tains a previously unrecognized conserved C-terminal LYR motif
and is predicted to ligate two [4Fe-4S] clusters (Table S5). As
only 14 of the 45 complex I subunits are required for core enzy-
matic activity (Fassone and Rahman, 2012), some of the acces-454 Cell Metabolism 19, 445–457, March 4, 2014 ª2014 Elsevier Inc.sory or supernumerary subunits may contribute to the assembly
and stability of the complex. Several of the LYR-containing sub-
units may aid insertion of the Fe-S clusters into the complex.
In our analysis, we also identified a third binding region for
HSC20 in residues 255–280 of SDHB. Our mutagenesis ana-
lyses demonstrated that the sequence K267K268X7K276K277 was
responsible for mediating the interaction with HSC20. SUCLG2,
a protein identified in our screen, which may provide succinyl-
CoA consumed in the first step of heme biosynthesis, contains
a similar consensus at its C terminus. Moreover, GLRX5, which
interacted with HSC20 in vivo, has a similar pattern of lysines
in the C-terminal region (K139K140X10K151K151). Notably, Grx5
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Motifs that Guide Iron Sulfur Cluster Targetinghomologs, including human GLRX5, serve as alternative
scaffolds for Fe-S cluster delivery to a subset of target proteins
(Shakamuri et al., 2012; Uzarska et al., 2013; Ye et al., 2010).
Our studies unveil a network of protein-protein interactions
that are key to assembly and function of complexes I–III in
eukaryotes, and likely also in bacteria, where the same machin-
ery is conserved. Numerous other Fe-S proteins, many of which
are not yet recognized, may be revealed by further studies of
proteins that contain the LYR motif, or further analyses of other
proteins identified in our Y2H screen.
EXPERIMENTAL PROCEDURES
Si-RNA Transfection of Human Cells
On-TARGET Plus SMART Pools against human HSC20 (L-017718-02), human
HSPA9 (L-004750-00), human HSPA14 (L-021084-01), an HSPA9 homolog,
and the non-targeting pool (D001810-10) were purchased from Thermo Scienti-
fic.HeLaorHEK293 cells (purchased fromATCC)were transfectedwith si-RNAs
usingDharmafect1 (ThermoScientific) according to themanufacturer’sprotocol.
Plasmids and Transfection of Human Cells
Plasmids used for expression in human cells were all pCMV-Entry based
(Origene) to allow the expression of constructs from a CMV-promoter (see
Table S4 for a full list). Constructs were C-terminally tagged either with HA
or with FLAG-MYC. Point mutations were introduced using the QuikChange
II Site-Directed Mutagenesis Kit (Stratagene). Plasmid transfections into
human cells were routinely performed with Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions.
Plasmids and Transformation in Yeast
The library of proteins (preys) was expressed as fusion to the GAL4 activation
domain (GAL4-AD) in pGADT7 and engineered to generate preys lacking the
mitochondrial targeting sequence to allow the Y2H interactions to take place
into the nucleus of yeast cells and to potentially activate the transcription of
four independent reporter genes (AUR1-C, ADE2, HIS3, and MEL1). In our
experiments we checked for activation of the HIS3 gene which allows for the
use of a small inhibitor, 3-amino-1, 2, 4- triazole (3-AT), to modulate the back-
ground and to thereby select for high activation of the HIS3 gene. The bait,
HSC20 (residues 29–235), was expressed as a fusion to the GAL4 binding
domain (GAL4-BD) in pGBKT7. PGBKT7-P53 and pGADT7-SV40-T-Ag, and
PGBKT7-RABEX5 and pGADT7-RABEP1 were used as positive controls.
The constructs generated for the Y2H assay were all pGBKT7 or pGADT7
based. The point mutations were introduced by using the QuikChange II
Site-Directed Mutagenesis Kit (Stratagene). Cotransformations into
S. cerevisiae AH109 strain were performed following a polyethylene glycol
(PEG)/LiAc-based method for preparing and transforming competent yeast
cells, using the YeastMaker Yeast Transformation System 2 (Clontech).
Cell Extracts and Fractionation
Whole-cell lysates were prepared with lysis buffer I: 25 mM Tris, 0.15 M NaCl,
1 mM EDTA, 1% NP-40, 5% glycerol (pH 7.4), protease, and phosphatase in-
hibitors. Cellular fractionation into cytosol and intact mitochondria was done
essentially as described (Frezza et al., 2007). The mitochondrial matrix fraction
was prepared after swelling of the mitochondrial outer membrane by hypoton-
ic shock, followed by sonication (four repeats of 5 s bursts at high settings
with 30 s pauses), supplementation with 150 mM NaCl and 5% glycerol, and
centrifugation at 20,000 3 g 30 min. The supernatant was saved as soluble
mitochondrial matrix fraction. The pellet was washed twice with 10 mM Tris/
MOPS, 1 mM EGTA/Tris, 0.2 M sucrose, finally resuspended in 20 mM TrisHCl
(pH 7.8), 0.4 M NaCl, 15% glycerol, 1 mM DTT, 1 mM PMSF, 0.5% digitonin,
incubated on ice for 15 min, and centrifuged at 20,0003 g 30 min. The super-
natant was saved as the mitochondrial membrane proteins.
Immunoprecipitation
The lysis buffer used for the immunoprecipitation (IP) experiments was pre-
pared as lysis buffer I supplemented with 2 mM ADP. FLAG- immunoprecipi-Cetations were performed using M2-FLAG beads (Sigma). IPs of endogenous
proteins or HA-immunoprecipitations were done by covalently coupling
the proper antibodies onto an amine-reactive resin (Pierce Co-IP kit, catalog
number 26149), following the manufacturer’s instructions. Whole-cell lysates
or subcellular fractions, as indicated, were incubated with beads for 4 hr
at 4 oC and then washed extensively with lysis buffer I. Bound proteins were
either eluted by incubation of beads with lysis buffer I containing 100 mg/ml
3 3 FLAG peptide for 1 hr at 4

C or with lysis buffer I containing 10 or
20 mg/ml HA peptide. Alternatively, acidic elution with Tris-glycine (pH 2.8)
for 10 min at 4C was performed for samples to be analyzed by SDS-PAGE
and immunoblot (IB). Aliquots, corresponding to 30%–40% of total or subcel-
lular lysates were run alongside the IP fractions onto the gels as inputs.
Native PAGE and Native Immunoblot
The Native PAGENovex Bis-Tris gel system (Invitrogen) was used for the anal-
ysis of native membrane protein complexes and native mitochondrial matrix
complexes, with the following modifications: only the light blue cathode buffer
was used; 20 mg of membrane protein extracts were loaded per well; the elec-
trophoresis was performed at 150 V for 1 hr and 250 V for 3.5 hr. For the native
IB, PVDF was used as the blotting membrane. The transfer was performed at
25 V for 4 hr at 4C. After transfer, the membrane was washed with 8% acetic
acid for 20 min to fix the proteins, and then rinsed with water before air drying.
The dried membrane was washed five to six times with methanol (to remove
residual Coomassie blue G-250), rinsed with water, and then blocked for
2 hr at room temperature in 5% milk, before incubating with the desired
antibodies overnight at 4C. In order to avoid strip and reprobing of the
same membrane, which might allow detection of signals from the previous
IBs, samples were loaded and run in replicates on adjacent wells of the
same gel, and probed independently with different antibodies.
Two-Dimensional Native/SDS-PAGE
Two-dimensional native/SDS-PAGE was performed by resolving the mito-
chondrial protein complexes in the first dimension, by BN-PAGE. Each lane
of the gel was excised, equilibrated in SDS buffer supplemented with reducing
agent, and then immersed in the alkylating solution for 15 min. For the second
dimension, the gel strip was fixed horizontally onto the NuPAGE 4%–12%
Bis-Tris Zoom Gel (Invitrogen), and the SDS-PAGE was performed.
Complex I and Complex II Activities
In-gel complex I and complex II activities were performed as described (Diaz
et al., 2009;Wittig et al., 2007). See theSupplemental Experimental Procedures.
Iron Incorporation Assay
The Fe55 incorporation assay into the mitochondrial respiratory chain com-
plexes was done essentially as described (Stehling et al., 2009), with several
modifications (see Supplemental Experimental Procedures).
In Vitro Transcription/Translation and Import into Isolated
Mitochondria
The cell-free E. coli expression system (Life Technologies), which couples
transcription/translation reactions to produce high yields of soluble, function-
ally active proteins, was used to synthesize HA-tagged SDHB to be imported
into isolated mitochondria, following the manufacturer’s instructions. The
mitochondrial binding and insertion assay was performed as described
(Yang et al., 2012). Briefly, mitochondria were isolated from HEK293 trans-
fected with wild-type HSC20-F/M or with HSC20HPD-AAA-F/M. Equal amounts
of in vitro synthesized SDHB-HA and isolated mitochondria were incubated,
for the designated time points, with ATP, creatine phosphate, creatine phos-
phokinase, methionine, MgCl2, KCl, DTT, sucrose, and HEPES buffered to a
pH of 7.5 with KOH. The reaction mixture was kept at 37C for the indicated
time points and then placed on ice. Mitochondria were washed and treated
with Proteinase K before lysis (in order to remove the amount of SDHB-HA
that was not imported into mitochondria). Extracts were then prepared,
followed by IP with an anti-HA to immunoprecipitate SDHB-HA. Elution was
performed with HA peptide. IBs to HSC20, ISCU, HSPA9, or SDHA were
then performed. Alternatively, FLAG/MYC-tagged SDHB wild-type or R46Q
mutant was synthesized in vitro, as previously described, and used for the
import into mitochondria isolated from HEK293. Extracts were prepared afterll Metabolism 19, 445–457, March 4, 2014 ª2014 Elsevier Inc. 455
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Motifs that Guide Iron Sulfur Cluster Targetingallowing the import to proceed for the indicated time points, and the IPs were
performed with anti-FLAG.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, five tables, and Supplemental
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